In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

The Association for Molecular Pathology announced the publication of best practice recommendations for clinical laboratories developing and performing homologous recombination deficiency (HRD) testing ...

A new hereditary condition has been discovered that affects patients' ability to repair DNA – leaving them both at greater ...

Experiments with tools designed to detect DNA damage reveal unique and conserved features of telomeres in cancer cells.

A study reveals significant genomic differences in metastatic prostate cancer among veterans, highlighting the need for ...

Drs Olga Brieieva and Martin Higgs discuss in vitro genomic models for predicting clinical resistance to PARP inhibitors for ...

As the quest to extend human lifespan gains momentum, a select group of scientists is pioneering efforts to reverse the aging process. Inside state-of-the-art laboratories, researchers are ...

FDA approves updated labeling for Talzenna plus Xtandi in men with HRR gene-mutated metastatic prostate cancer, showing a ...

NEW YORK – The Association for Molecular Pathology on Tuesday published best practice recommendations for the design and validation of clinical tests for homologous recombination deficiency. The ...

Discover how sugar quietly damages your liver through dangerous mechanisms. Learn about fatty liver disease, inflammation, ...

But when a Harvard-trained gastroenterologist like Dr Saurabh Sethi points to something as simple as a daily drink to support ...

Scientists have made an important discovery to date in the study and treatment of BRCA1-deficient cancers and PARP inhibitor ...